Repositioning of the offer and restructuring show their first positive effects.
Details about funding agreement and proposed combination with DMS Group.
Several partnership agreements signed in Europe, strengthening Intrasense positions on its historical market.
Issue of Convertible Bonds with Share (OCA) for a maximum nominal amount of 3.5 millions euros over 3 years.
Both companies are finalizing the contribution agreement and the exchange parity.
Worldwide launching of the latest version of Myrian® during the Chinese hospital information systems tradeshow.
This 5-year agreement guarantees Intrasense recurring revenues with this new partner.
Intrasense and DMS Group enter exclusive negotiations for the contribution of DMS Group medical imaging activities to Intrasense.
Intrasense announces its 2017 financial results and strategy for 2018.
Intrasense introduces Myrian® new features and proves its seamless integration capabilities within any health information system.
Select your choice...Receive newsGet in touch with the investor serviceOther
By ticking this box, I agree to my data being used by Intrasense to respond to my request and to receive appropriate communications or information. I may withdraw my consent at any time by writing to the Data Protection Officer at dpo@intrasense.fr. For further information, please consult our Privacy Policy.
Please leave this field empty.
En cochant cette case, j'accepte que mes données soient utilisées par Intrasense pour répondre à ma demande et recevoir des communications ou des informations appropriées. Je peux retirer mon consentement à tout moment en écrivant au Délégué à la protection des données à dpo@intrasense.fr. Pour en savoir plus, consultez notre Politique de Confidentialité.
